PMDA drug package insert
ゼリス液II
PMDA OTC drug · （名）東宝製薬 · package insert Oct 23, 2020
Key facts
| Brand names | ゼリス液II |
|---|---|
| Companies | 製造販売元／大生堂薬品工業（株）,販売会社／（名）東宝製薬 |
| Product type | OTC drug |
| OTC risk class | 第「２」類医薬品 |
| OTC dosage form | 液剤 |
| OTC effect category | 鎮咳去痰薬 |
| Package insert date | Oct 23, 2020 |
| PMDA document key | 400068_K2008000027 |
| PMDA company code | 400068 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: